Haisco Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Haisco Pharmaceutical Group has a total shareholder equity of CN¥4.3B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 47.3%. Its total assets and total liabilities are CN¥6.8B and CN¥2.6B respectively. Haisco Pharmaceutical Group's EBIT is CN¥322.1M making its interest coverage ratio 19.8. It has cash and short-term investments of CN¥1.5B.
Key information
47.3%
Debt to equity ratio
CN¥2.03b
Debt
Interest coverage ratio | 19.8x |
Cash | CN¥1.51b |
Equity | CN¥4.28b |
Total liabilities | CN¥2.56b |
Total assets | CN¥6.84b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 002653's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 002653's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 002653's net debt to equity ratio (12.1%) is considered satisfactory.
Reducing Debt: 002653's debt to equity ratio has reduced from 50.5% to 47.3% over the past 5 years.
Debt Coverage: 002653's debt is well covered by operating cash flow (22%).
Interest Coverage: 002653's interest payments on its debt are well covered by EBIT (19.8x coverage).